Overview

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Status:
Active, not recruiting

Trial end date:
2021-02-13

Target enrollment:

Participant gender:

Summary

This study will assess the efficacy of oral vancomycin prophylaxis in preventing recurrent Clostridium difficile infection in hospitalized patients requiring oral or intravenous antibiotics for a suspected or confirmed bacterial infection.

Phase:

Phase 4

Details

Lead Sponsor:

University of Nevada, Reno

Collaborator:

Renown Regional Medical Center

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Vancomycin